Zymeworks Statistics

Total Valuation

Zymeworks has a market cap or net worth of $2.06 billion. The enterprise value is $1.81 billion.

Market Cap	2.06B
Enterprise Value	1.81B

Important Dates

The next confirmed earnings date is Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

Zymeworks has 73.75 million shares outstanding. The number of shares has decreased by -0.61% in one year.

Current Share Class	73.75M
Shares Outstanding	73.75M
Shares Change (YoY)	-0.61%
Shares Change (QoQ)	-0.58%
Owned by Insiders (%)	1.29%
Owned by Institutions (%)	51.15%
Float	68.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	22.78
PS Ratio	19.45
Forward PS	6.80
PB Ratio	7.94
P/TBV Ratio	8.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	17.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.88, with a Debt / Equity ratio of 0.07.

Current Ratio	5.88
Quick Ratio	5.52
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.72% and return on invested capital (ROIC) is -127.65%.

Return on Equity (ROE)	-26.72%
Return on Assets (ROA)	-14.29%
Return on Invested Capital (ROIC)	-127.65%
Return on Capital Employed (ROCE)	-30.42%
Weighted Average Cost of Capital (WACC)	10.76%
Revenue Per Employee	$401,383
Profits Per Employee	-$307,311
Employee Count	264
Asset Turnover	0.26
Inventory Turnover	n/a

Taxes

In the past 12 months, Zymeworks has paid $1.38 million in taxes.

Income Tax	1.38M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +122.24% in the last 52 weeks. The beta is 1.20, so Zymeworks's price volatility has been higher than the market average.

Beta (5Y)	1.20
52-Week Price Change	+122.24%
50-Day Moving Average	25.15
200-Day Moving Average	20.83
Relative Strength Index (RSI)	59.14
Average Volume (20 Days)	600,528

Short Selling Information

The latest short interest is 4.65 million, so 6.31% of the outstanding shares have been sold short.

Short Interest	4.65M
Short Previous Month	4.46M
Short % of Shares Out	6.31%
Short % of Float	6.76%
Short Ratio (days to cover)	7.55

Income Statement

In the last 12 months, Zymeworks had revenue of $105.97 million and -$81.13 million in losses. Loss per share was -$1.08.

Revenue	105.97M
Gross Profit	-31.04M
Operating Income	-92.55M
Pretax Income	-79.75M
Net Income	-81.13M
EBITDA	-84.82M
EBIT	-92.55M
Loss Per Share	-$1.08

Full Income Statement

Balance Sheet

The company has $228.80 million in cash and $18.27 million in debt, giving a net cash position of $252.32 million or $3.42 per share.

Cash & Cash Equivalents	228.80M
Total Debt	18.27M
Net Cash	252.32M
Net Cash Per Share	$3.42
Equity (Book Value)	268.50M
Book Value Per Share	3.60
Working Capital	206.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$33.01 million and capital expenditures -$1.52 million, giving a free cash flow of -$34.53 million.

Operating Cash Flow	-33.01M
Capital Expenditures	-1.52M
Depreciation & Amortization	7.73M
Net Borrowing	n/a
Free Cash Flow	-34.53M
FCF Per Share	-$0.47

Full Cash Flow Statement

Margins

Gross margin is -29.29%, with operating and profit margins of -87.34% and -76.56%.

Gross Margin	-29.29%
Operating Margin	-87.34%
Pretax Margin	-75.26%
Profit Margin	-76.56%
EBITDA Margin	-80.05%
EBIT Margin	-87.34%
FCF Margin	n/a

Dividends & Yields

Zymeworks does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.61%
Shareholder Yield	0.61%
Earnings Yield	-3.94%
FCF Yield	-1.68%

Analyst Forecast

The average price target for Zymeworks is $38.90, which is 39.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$38.90
Price Target Difference	39.23%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	24.78%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Zymeworks has an Altman Z-Score of 4.95 and a Piotroski F-Score of 4.

Altman Z-Score	4.95
Piotroski F-Score	4